Departamento de Ciência e Tecnologia de Alimentos, Centro de Ciências Agrárias, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Braz J Microbiol. 2013 Oct 30;44(2):651-6. doi: 10.1590/S1517-83822013000200046. eCollection 2013.
The objective of this study was to identify mutations in the Quinolone Resistance Determining sources Regions (QRDR) of the gyrA, gyrB, parC, and parE genes and to determine if any of the qnr variants or the aac(6')-Ib-cr variant were present in strains of Salmonella spp. isolated in Brazil. A total of 126 Salmonella spp. strains from epidemic (n = 114) and poultry (n = 12) origin were evaluated. One hundred and twelve strains (88.8%) were resistant to nalidixic acid (NAL) and 29 (23.01%) showed a reduced susceptibility to ciprofloxacin (Cip). The mutations identified were substitutions limited to the QRDR of the gyrA gene in the codons for Serine 83, Aspartate 87 and Alanine 131. The sensitivity to NAL seems to be a good phenotypic indication of distinguishing mutated and non-mutated strains in the QRDR, however the double mutation in gyrA did not cause resistance to ciprofloxacin. The qnrA1 and qnrB19 genes were detected, respectively, in one epidemic strain of S. Enteritidis and one strain of S. Corvallis of poultry origin. Despite previous detection of qnr genes in Brazil, this is the first report of qnr gene detection in Salmonella, and also the first detection of qnrB19 gene in this country. The results alert for the continuous monitoring of quinolone resistance determinants in order to minimize the emergence and selection of Salmonella spp. strains showing reduced susceptibility or resistance to quinolones.
本研究旨在鉴定巴西分离的沙门氏菌中喹诺酮类药物耐药决定区(QRDR)的 gyrA、gyrB、parC 和 parE 基因中的突变,并确定是否存在任何 qnr 变体或 aac(6')-Ib-cr 变体。共评估了 126 株来自流行(n=114)和家禽(n=12)来源的沙门氏菌菌株。112 株(88.8%)对萘啶酸(NAL)耐药,29 株(23.01%)对环丙沙星(Cip)的敏感性降低。鉴定出的突变仅限于 gyrA 基因的 QRDR 中的密码子,涉及丝氨酸 83、天冬氨酸 87 和丙氨酸 131。NAL 的敏感性似乎是区分 QRDR 中突变和非突变菌株的良好表型指标,但 gyrA 中的双突变并未导致对环丙沙星的耐药性。分别在一株来自流行的肠炎沙门氏菌和一株来自家禽的科瓦利斯沙门氏菌的菌株中检测到了 qnrA1 和 qnrB19 基因。尽管巴西之前已经检测到了 qnr 基因,但这是首次在沙门氏菌中检测到 qnr 基因,也是该国首次检测到 qnrB19 基因。这些结果提醒人们要持续监测喹诺酮类药物耐药决定因素,以尽量减少对喹诺酮类药物敏感性降低或耐药的沙门氏菌菌株的出现和选择。